You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / CE

Multiple Sclerosis: Insights Into Optimal Care

  • Authors: Michael S. Okun, MD; Patricia K. Coyle, MD, FAAN, FANA; Mark S. Freedman, MD, FAAN, FANA, FRCPC; Stephen Krieger, MD; Clyde E. Markowitz, MD
  • CME / CE Released: 10/11/2022
  • Valid for credit through: 10/11/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™

    Nurses - 1.25 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

    IPCE: 1.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists, nurse practitioners (NPs), and nurses involved in the care of patients with multiple sclerosis (MS).

The goal of this activity is that learners will be better able to diagnose and comprehensively manage the symptoms of MS.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • McDonald criteria for the diagnosis of MS 
    • Factors that impact the selection of an initial disease-modifying therapy (DMT) for the management of MS
    • Clinical data for pharmacotherapies for the management of progressive forms of MS 
    • Mechanistic differences between progressive and relapsing/refractory forms of MS 
    • Common symptomatic manifestations of MS 
    • Therapeutic options for the management of specific symptomatic manifestations of MS 
  • Have increased confidence when collaborating with
    • The interprofessional team to manage specific symptomatic manifestations of MS 
  • Have greater competence related to
    • Utilizing the McDonald criteria for the diagnosis of MS
    • Personalizing the initial selection of a DMT for the management of MS


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Conference Chair

  • Michael S. Okun, MD

    Professor and Chair of Neurology  
    University of Florida Health 
    Director, Norman Fixel Institute for Neurological Diseases 
    Gainesville, Florida, United States

    Disclosures

    Michael S. Okun, MD, has no relevant financial relationships.​

Session Chair

  • Patricia K. Coyle, MD, FAAN, FANA

    Professor and Vice Chair, Clinical Affairs​
    Director, MS Comprehensive Care Center​
    Stony Brook University Medical Center
    Stony Brook, New York, United States

    Disclosures

    Patricia K. Coyle, MD, FAAN, FANA, has the following relevant financial relationships:
    Consultant or advisor for: Accordant; Alexion; Biogen; Bristol Myers Squibb; Celgene; GlaxoSmithKline; Horizon Therapeutics; Janssen; Mylan; Novartis; Sanofi Genzyme; TG Therapeutics; Viela Bio
    Speaker or member of speakers bureau for: Biogen; Janssen
    Research funding from: Actelion; Alkermes; Celgene; CorEvitas LLC; Genentech/Roche; MedDay; Novartis; Sanofi Genzyme
    Contracted researcher for: Actelion; Alkermes; Celgene; CorEvitas LLC; Genentech/Roche; MedDay; Novartis; Sanofi Genzyme

Faculty

  • Mark S. Freedman, MD, FAAN, FANA, FRCPC

    Senior Scientist, Neuroscience Program​
    Ottawa Hospital Research Institute​
    Professor of Medicine, Neurology​
    University of Ottawa​
    Director, MS Research Unit, Neurology​
    Ottawa Hospital--General Campus​
    Ottawa, Ontario, Canada

    Disclosures

    Mark S. Freedman, MD, FAAN, FANA, FRCPC, has the following relevant financial relationships:
    Consultant or advisor for: Atara Biotherapeutics; Bayer; Biogen; Bristol Myers Squibb/Celgene; Celestra; EMD Serono; Novartis; Roche; Sanofi Genzyme; Teva
    Speaker or member of speakers bureau for: EMD Serono; Sanofi Genzyme
    Research funding from: Sanofi Genzyme
    Contracted researcher for: Atara Biotherapeutics; Bayer; Biogen; Bristol Myers Squibb/Celgene; EMD Serono; Novartis; Roche; Sanofi Genzyme

  • Stephen Krieger, MD

    Professor of Neurology​
    Icahn School of Medicine at Mount Sinai​
    New York, New York, United States

    Disclosures

    Stephen Krieger, MD, has the following relevant financial relationships:
    Consultant or advisor for: Biogen; EMD Serono; Genentech; Novartis; Octave; Sanofi; TG Therapeutics
    Speaker or member of speakers bureau for: Biogen; EMD Serono; Genentech
    Research funding from: Biogen; Bristol Myers Squibb; Novartis; Sanofi

  • Clyde E. Markowitz, MD

    Director, Multiple Sclerosis Center
    Hospital of the University of Pennsylvania
    Associate Professor of Neurology
    University of Pennsylvania School of Medicine
    Philadelphia, Pennsylvania, United States

    Disclosures

    Clyde E. Markowitz, MD, has the following relevant financial relationships:
    Consultant or advisor for: Alexion; ANI; Biogen; Bristol Myers Squibb; EMD Serono; Genentech/Roche; Genzyme/Sanofi; Horizon Therapeutics; Janssen/Actelion; Novartis; Teva; TG Therapeutics
    Research funding from: Genentech; Novartis

Editors

  • Meg Monday

    Senior Director, Content Development, Medscape, LLC 

    Disclosures

    Meg Monday, has no relevant financial relationships. 

  • Lisette Arnaud-Hevi, PhD

    Medical Education Director, Medscape, LLC 

    Disclosures

    Lisette Arnaud-Hevi, PhD, has no relevant financial relationships.  

Compliance Reviewer/Nurse Planner

  • Lisa Simani, APRN, MS, ACNP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

    For Nurses

  • Awarded 1.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.75 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Multiple Sclerosis: Insights Into Optimal Care

Authors: Michael S. Okun, MD; Patricia K. Coyle, MD, FAAN, FANA; Mark S. Freedman, MD, FAAN, FANA, FRCPC; Stephen Krieger, MD; Clyde E. Markowitz, MDFaculty and Disclosures

CME / CE Released: 10/11/2022

Valid for credit through: 10/11/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Bringing the McDonald Criteria to Life: Diagnosing MS in the Clinic

Learn how the understanding of the MS pathology informs the diagnosis criteria.
Clyde E. Markowitz, MD

Starting Therapy in MS: Balancing Efficacy and Safety

Dr Freedman reviews the patient and prognosis factors to consider for a personalized treatment approach.
Mark S. Freedman, MD, FAAN, FANA, FRCPC

Progress in Progressive MS: Where Do We Stand?

Dr Patricia Coyle presents some of the latest clinical studies data for the management of progressive MS.
Patricia K. Coyle, MD, FAAN, FANA

Comprehensive Care in MS: Symptoms and Treatment

Dr Krieger discusses how the management of MS symptoms can make a difference in the patient quality of life.
Stephen Krieger, MD
 

Learning Feedback Questions

Please answer these questions to complement your learning experience.